get a key
steadybase-$ company CLGN
account_id none on file
legal_name CollPlant Biotechnologies Ltd
ticker CLGN
cik 1631487
domain collplant.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 0 filings 6 executives 6 family 0
why_nownone on file
callsnone on file
filings
Yehiel Tal | 73 | Chief Executive Officer and Interim Chairman of the Board

filing / Mar 26, 2026 / receipt

Oren Fahimipoor | 44 | Vice President, Operations

filing / Mar 26, 2026 / receipt

Dr. Philippe Bensimon | 60 | Vice President, Regulatory Affairs and Quality Assurance

filing / Mar 26, 2026 / receipt

Jasmine Seror | 44 | Vice President, Product Development

filing / Mar 26, 2026 / receipt

Bowman Bagley | 34 | Vice President, Commercial North America

filing / Mar 26, 2026 / receipt

Bar Abelis | 34 | Vice President, Legal

filing / Mar 26, 2026 / receipt

executives
Bar Abelis Vice President, Legal - receipt
Bowman Bagley Vice President, Commercial North America - receipt
Dr. Philippe Bensimon Vice President, Regulatory Affairs and Quality Assurance - receipt
Jasmine Seror Vice President, Product Development - receipt
Oren Fahimipoor Vice President, Operations - receipt
Yehiel Tal Chief Executive Officer and Interim Chairman of the Board - receipt
familynone on file
upcoming
2026-11-25 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$